Your browser doesn't support javascript.
loading
B cell immunofocusing and repriming in two HIV-1 Env immunization regimens.
DeLuca, Jenna M; Blasi, Maria; Jha, Shalini; Shen, Xiaoying; Pollara, Justin; Kerkau, Melissa; Purwar, Mansi; Carnathan, Diane G; Negri, Donatella; Cara, Andrea; Wollenberg, Kurt; Saunders, Kevin O; Lu, Shan; Silvestri, Guido; Weiner, David B; Klotman, Mary E; Ferrari, Guido; Moody, M Anthony; Bonsignori, Mattia.
  • DeLuca JM; Translational Immunobiology Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Blasi M; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Jha S; Department of Medicine, Duke University, Durham, NC, USA.
  • Shen X; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Pollara J; Department of Surgery, Duke University, Durham, NC, USA.
  • Kerkau M; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Purwar M; Department of Surgery, Duke University, Durham, NC, USA.
  • Carnathan DG; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Negri D; Department of Surgery, Duke University, Durham, NC, USA.
  • Cara A; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Wollenberg K; Department of Surgery, Duke University, Durham, NC, USA.
  • Saunders KO; Wistar Institute, Philadelphia, PA, USA.
  • Lu S; Emory National Primate Research Center and Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA, USA.
  • Silvestri G; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Weiner DB; Department of Medicine, Duke University, Durham, NC, USA.
  • Klotman ME; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Ferrari G; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.
  • Moody MA; Department of Medicine, Duke University, Durham, NC, USA.
  • Bonsignori M; National Center for Global Health, Istituto Superiore di Sanità, Rome, Italy.
Res Sq ; 2024 Apr 08.
Article en En | MEDLINE | ID: mdl-38659814
ABSTRACT
Diverse and rapidly mutating viruses pose challenges to immunogen and vaccine design. In this study, we evaluated the ability of memory B-cells obtained from two independent NHP trials to cross-react with individual HIV-1 vaccine components of two different multivalent immunization strategies. We demonstrated that while an HIV-1 Env multiclade, multivalent immunization regimen resulted in a dominant memory B-cell response that converged toward shared epitopes, in a sequential immunization with clonally-related non-stabilized gp140 HIV-1 Envs followed by SOSIP-stabilized gp140 trimers, the change in immunogen format resulted in repriming of the B-cell response.